AUPH Market Cap & Key Metrics
Aurinia Pharmaceuticals Inc.
$17.26
+$0.65(+3.91%)
65
Overall
70
Value
63
Tech
63
Quality
Market Cap
$2.21B
Volume
142.23K
52W Range
$10.90 - $19.25
Target Price
$17.75
AUPH market cap is $2.21B. This page lists Aurinia Pharmaceuticals Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
AUPH Key Metrics
- Market cap
- $2.21B
- P/E ratio (current-year EPS estimate)
- 19.18
- EPS estimate, current year
- $0.90
- EPS growth, 3-year
- +68.87%
- Value score
- 70
- Quality score
- 63
- Technical score
- 63
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $271.35M | $216.19M | $158.53M | $103.47M | $45.60M |
| EBITDA | $127.76M | $10.30M | -$58.43M | -$106.35M | -$177.44M |
| EPS | $2.14 | $0.04 | $-0.54 | $-0.76 | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AUPH | $17.26 | +3.9% | 142.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aurinia Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW